Article
The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques - 1 Jan 2023
Forgerini Marcela, Urbano Gustavo, De Nadai Tales Rubens, Batah Sabrina Setembre, Fabro Alexandre Todorovic, De Carvalho Mastroianni Patrícia
Abstract excerpt
Purpose: To investigate whether interindividual variability in the CYP2C9 (*2 and *3 alleles) and VKORC1 (rs9923231) genes is associated with increased risk of upper gastrointestinal bleeding (UGIB) in users of non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA). Methods: A full case-control study including 200 cases of patients diagnosed with UGIB and 706 controls was conducted in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
